France· FR:69086254
TRAVOPROST/TIMOLOL ZENTIVA 40 microgrammes/mL + 5 mg/mL, collyre en solution
A medicinal product containing maléate de timolol + travoprost, registered in France by ZENTIVA FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MALÉATE DE TIMOLOL + TRAVOPROST
- Manufacturer
- ZENTIVA FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009301051911 flacon(s) polypropylène de 5 ml avec embout(s) polyéthylène basse densité (PEBD)EUR 7.04
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Maléate de timolol + travoprost in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDuoTrav 40micrograms/ml / 5mg/ml eye dropsMawdsley-Brooks & Company Ltd
- CzechiaDUOTRAVNovartis Europharm Limited, Dublin
- GermanyJokathPharmathen S.A.
- NetherlandsDuoTrav 40 microgram/ml + 5 mg/ml oogdruppels, oplossingNovartis Europharm Limited
- ItalyALDUOVIZGENETIC S.P.A.
- SpainDIXANOR 40 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCIONLaboratorio Stada S.L.
- SwitzerlandDuotrav
- PolandDuoTravNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Kivizidiale, Syntragut
- Belgium · Filiop, Kivizidiale
- Bulgaria · Даверис-Т, Кивизидиал
- Cyprus · Kivizidiale, Tratim
- Czechia · Kivizidiale, Travoprost/Timolol Olikla
- Germany · Kivizidiale, Syntragut
- Denmark · Eltenodo, Filiop
- Estonia · Travoprost/Timolol Elvim, Travoprost/Timolol Viatris
- Spain · Filiop, Kivizidiale
- Finland · Travoprost/Timolol Stada, Trevicopto Comp
- United Kingdom (Northern Ireland) · Travoprost + Timolol Blumont Pharma, Travoprost/Timolol Aspire
- Greece · Eltenodo, Kivizidiale
- Croatia · Kivizidiale
- Hungary · Kivizidiale, Travoprost/Timolol Polpharma
- Iceland · Duotrav, Travoprost/Timolol Medical Valley
- Italy · Alduoviz, Enteglock
- Liechtenstein · Duotrav
- Lithuania · Travoprost/Timolol Elvim, Travoprost/Timolol Polpharma
- Luxembourg · Filiop, Kivizidiale
- Latvia · Travoprost/Timolol Elvim, Travoprost/Timolol Polpharma
- Netherlands · Filiop, Kivizidiale
- Norway · Duotrav, Travabloc
- Poland · Kivizidiale, Rozaduo
- Portugal · Nexotrav, Syntragut
- Romania · Kivizidiale, Travoprost/Timolol Zentiva
- Sweden · Travabloc, Travoprost/Timolol Medical Valley
- Slovakia · Kivizidiale, Travoprost/Timolol Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1aca283f-6178-4dab-b3e7-2598e1f259d2 GET /v1/drugs/1aca283f-6178-4dab-b3e7-2598e1f259d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69086254",
"date_amm": "2017-10-02",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "MALÉATE DE TIMOLOL + TRAVOPROST",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about maléate de timolol + travoprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.